Amicus Therapeutics

Patent cliffs & loss of exclusivity

Amicus Therapuetics is a biotechnology company developing therapies to cure rare diseases.

Company

AngelList URLhttps://angel.co/amicus-therapeutics
Apple App Store URLhttps://apps.apple.com/gb/app/amicus-assist-myday/id1436305956
CAGE Code603U6
Legal NameAmicus Therapeutics, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/amicus-therapeutics
Facebook URLhttps://www.facebook.com/pages/Amicus-Therapeutics/357833324290284
Full Address6500 Trans-Canada Road, 4th Floor Pointe-Claire, Québec H9R 0A5

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. Pombiliticipaglucosidase alfa-atgaBiologicSep 2035
  2. OPFOLDAMIGLUSTATSmall mol.Sep 2038
  3. GALAFOLDMIGALASTAT HYDROCHLORIDESmall mol.Jan 2042

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Amicus Therapeutics — patent cliffs & loss of exclusivity | CliffBio